Ardelyx, Inc. (ARDX) Financials

ARDX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 575.9 million 426.9 million
March 31, 2026 504.5 million 355.9 million
Dec. 31, 2025 502.8 million 335.9 million
Sept. 30, 2025 486.2 million 331.9 million

ARDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.4 million 15.3 million
March 31, 2026 -32.3 million 14.2 million
Dec. 31, 2025 20.6 million 12.4 million
Sept. 30, 2025 209000 12.7 million

ARDX Net Income

No data available :(

ARDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 281.8 million 251.8 million 4.4 million
March 31, 2026 238.1 million 203.5 million 4.7 million
Dec. 31, 2025 264.7 million 206.5 million 3.6 million
Sept. 30, 2025 242.7 million 202.1 million 5.5 million

ARDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 248.1 million
March 31, 2026 245.9 million
Dec. 31, 2025 243.6 million
Sept. 30, 2025 241.9 million

ARDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 13000 26.1 million 101.4 million -
March 31, 2026 69000 20.2 million 102.3 million -
Dec. 31, 2025 361000 21.9 million 86.4 million -
Sept. 30, 2025 156000 17.2 million 83.6 million -

ARDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 120.9 million 5.8 million
March 31, 2026 94.5 million 4.8 million
Dec. 31, 2025 125.2 million 11.8 million
Sept. 30, 2025 110.3 million 4.9 million

ARDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARDX

Price: $4.06

52 week price:
3.89
8.40

Earnings Per Share: -0.23 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 8.1 million

Ebitda: -20.5 million

Market Capitalization: 1.0 billion

Links: